驅動卵巢纖維化的關鍵分子路徑包括轉化生長因子-β (TGF-β)/Smad訊號路徑、Wnt/β-catenin路徑和PI3K/Akt通路,
這些路徑調控纖維母細胞活化、細胞外基質重塑和組織硬化。
纖維化卵巢間質的特徵是I型和III型膠原蛋白、纖維連接蛋白和透明質酸含量升高,從而破壞正常的卵泡發生和類固醇生成。卵巢纖維化也與多囊性卵巢症候群、卵巢早衰和子宮內膜異位症等生殖系統疾病相關,
目前治療策略集中在吡非尼酮等抗纖維化藥物、TGF-β抑制劑和氧化壓力調節,以及乾細胞療法等新興療法。
. 2026 Jan 7;32(1):gaaf058. doi: 10.1093/molehr/gaaf058.Molecular mechanisms of ovarian fibrosis
Ovarian fibrosis is increasingly recognized as a pivotal factor contributing to ovarian ageing, dysfunction, and female infertility. It results from chronic or repetitive ovarian injury, such as that caused by repeated ovulation, which induces inflammation and excessive extracellular matrix (ECM) deposition, predominantly by activated fibroblasts and myofibroblasts. The key molecular pathways driving ovarian fibrosis include transforming growth factor-beta (TGF-β)/Smad signalling, Wnt/β-catenin, and PI3K/Akt pathways, which orchestrate fibroblast activation, ECM remodelling, and tissue stiffening. Elevated collagen types I and III, fibronectin, and hyaluronan characterize the fibrotic ovarian stroma, disrupting normal folliculogenesis and steroidogenesis. Ovarian fibrosis is also implicated in reproductive pathologies such as polycystic ovary syndrome, premature ovarian insufficiency and endometriosis, and may contribute to an increased risk of ovarian cancer, although definitive causal links require further elucidation. Current therapeutic strategies remain largely experimental, focusing on antifibrotic agents such as pirfenidone, TGF-β inhibitors, and modulation of oxidative stress, alongside emerging interventions such as stem cell therapies, which are offer potential avenues for intervention in the ovary. This review synthesizes current insights into the cellular and molecular mechanisms driving ovarian fibrosis, its association with reproductive disorders, and emerging therapeutic strategies. It underscores key knowledge gaps and emphasizes the need for future research focused on fibroblast activation, inflammatory signalling, and immune-ECM interactions to facilitate the development of targeted, long-term interventions aimed at preventing or reversing ovarian fibrosis and preserving female fertility.
沒有留言:
張貼留言